Opko Health OPK Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Gross Profit by Business | ||||||
| Diagnostics | $60.64M-3.6% | $62.92M-20.0% | $78.68M+3.2% | $76.27M-4.5% | $79.87M+1.7% | |
| Pharmaceutical | $148.44M+3.8% | $143.02M-3.3% | $147.89M+5.2% | $140.54M+1.0% | $139.2M-0.5% | |
| Revenue by Product | ||||||
| Rayaldee | $59.08M-0.5% | $59.39M-4.8% | $62.37M-1.6% | $63.36M-5.8% | $67.25M-3.0% | |
| Transfer Of Intellectual Property And Other | $81.4M+2.1% | $79.7M-10.6% | $89.11M+6.6% | $83.58M+3.3% | $80.92M+4.5% | |
| Revenue by Geography | ||||||
| CL | $62.71M+0.5% | $62.38M+2.5% | $60.88M-3.5% | $63.09M-2.5% | $64.69M-0.5% | |
| ES | $28.33M+6.0% | $26.72M+1.6% | $26.31M+0.2% | $26.27M+3.4% | $25.41M+3.2% | |
| IE | $55.6M+8.2% | $51.4M+9.1% | $47.12M+1.2% | $46.55M+4.3% | $44.65M-7.7% | |
| IL | $450K-14.0% | $523K-60.6% | $1.33M-4.0% | $1.38M-17.9% | $1.69M-4.9% | |
| MX | $26.23M+2.8% | $25.52M+4.1% | $24.51M+4.7% | $23.4M+1.7% | $23.01M-3.6% | |
| Other Countries | $4.43M+3.8% | $4.27M+5.8% | $4.04M+9.1% | $3.7M+6.1% | $3.49M+11.6% | |
| US | $403.36M-7.5% | $436.06M-8.8% | $477.89M-4.4% | $499.63M-5.1% | $526.47M-3.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Opko Health break its business down?
- Opko Health (OPK) reports gross profit by business across 2 parts — Diagnostics and Pharmaceutical. Each is extracted from the segment footnotes and tracked over time.
- Where does Opko Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Opko Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
